Soberon X, Covarrubias L, Bolivar F
Gene. 1980 May;9(3-4):287-305. doi: 10.1016/0378-1119(90)90328-o.
In vitro recombinant DNA experiments involving restriction endonuclease fragments derived from the plasmids pBR322 and pBR325 resulted in the construction of two new cloning vehicles. One of these plasmids, designated pBR327, was obtained after an EcoRII partial digestion of pBR322. The plasmid pBR327 confers resistance to tetracycline and ampicillin, contains 3273 base pairs (bp) and therefore is 1089 bp smaller than pBR322. The other newly constructed vector, which has been designated pBR328, confers resistance to chloramphenicol as well as the two former antibiotics. This plasmid contains unique HindIII, BamHI and SalI sites in the tetracycline resistance gene, unique PvuI and PstI sites in the ampicillin resistance gene and unique EcoRI, PvuII and BalI sites in the chloramphenicol resistance gene. The pBR328 plasmid contains approx. 4900 bp.
涉及源自质粒pBR322和pBR325的限制性内切酶片段的体外重组DNA实验,构建了两种新的克隆载体。其中一种质粒命名为pBR327,是在pBR322经EcoRII部分消化后获得的。质粒pBR327赋予对四环素和氨苄青霉素的抗性,含有3273个碱基对(bp),因此比pBR322小1089 bp。另一种新构建的载体命名为pBR328,赋予对氯霉素以及前两种抗生素的抗性。该质粒在四环素抗性基因中含有独特的HindIII、BamHI和SalI位点,在氨苄青霉素抗性基因中含有独特的PvuI和PstI位点,在氯霉素抗性基因中含有独特的EcoRI、PvuII和BalI位点。pBR328质粒约含4900 bp。